期刊文献+

硼替佐米上调fas、bcl2l12、caspase-9和caspase-3基因表达 被引量:1

Up-regulation of mRNA expressions of fas,bcl-2,bim,bax,caspase-3,caspase-9,and bcl2l12 in K562 treated with bortezomib
下载PDF
导出
摘要 目的:探讨硼替佐米诱导慢性粒细胞白血病细胞株K562细胞凋亡及新基因bcl2l12在其中的作用。方法:MTT比色法观察硼替佐米对K562细胞的生长抑制作用;Annexin-V标记和线粒体跨膜电位(Δψm)分析细胞凋亡;RT-PCR方法检测0、6、12和24hfas、bcl2l12、bcl-2、bim、bax、caspase-3和caspase-9基因表达变化。结果:硼替佐米抑制K562细胞生长呈时间和剂量依赖性,24h和48h半数抑制浓度分别为161.41nmol/L和96.33nmol/L;硼替佐米诱导K562细胞凋亡,12h Annexin-V阳性细胞就开始增高,并呈时间依赖性,Δψm减低;RT-PCR显示fas、bcl2l12、caspase-3和caspase-9表达增高,但bcl-2、bim和bax表达无明显改变。结论:硼替佐米可以抑制K562生长并诱导凋亡,上调fas、bcl2l12,使线粒体膜电位下降,激活caspase-9和caspase-3基因,促使DNA发生断裂可能是其诱导凋亡的机制之一。 AIM: To detect the treatment of K562 leukemia cells with bortezomib altering the expression of genesfas, bcl-2, bcl2112, bim, bax, caspase -9 and caspase -3. METHODS: MTT assay was used to detect the inhibition of proliferation. Apoptosis was detected by Annexin - V staining and mitochondrial transmembrane potential (△ψm). RT - PCR was used to analyze the mRNA expressions offas, bcl - 2, bcl2112, bim, bax, caspase - 3 and caspase - 9. RESULTS: Bortezomib caused a time - and dose - dependent inhibition of cell proliferation and IC50 of 24 h and 48 h were 161.41 nmol/L and 96. 33 nmol/L, respectively. At the concentration of 104 nmol/L, bortezomib induced apoptosis in a timedependent manner, including increasing annexin -V poSitivity and decreasing the △ψm. RT- PCR showed that bortezomib up- regulated the mRNA expression offas, bcl2112, caspase- 9 and caspase- 3, but mRNA expressions of bcl - 2, bim and bax did not changed obviously. CONCLUSION: Bortezomib inhibits the proliferation of K562 and induces apoptosis, in which fas, bcl2112, caspase - 9 or caspase - 3 gene is one of the main genes taking part in.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2009年第5期883-887,共5页 Chinese Journal of Pathophysiology
基金 宁波市医学科技计划资助项目(No.200520)
关键词 硼替佐米 K562细胞 基因 bcl2l12 半胱氨酸天冬氨酸蛋白酶类 Bortezomib K562 cells Genes, bcl2112 Caspases
  • 相关文献

参考文献15

  • 1Kabore AF, Sun J, Hu X, et al. The TRAIL apoptotic pathway mediates proteasome inhibitor induced apoptosis in primary chronic lymphocytic leukemia cells [ J ]. Apoptosis, 2006, 11(7) : 1175 -1193.
  • 2Cardoso F, Durbecq V, Laes JF, et al. Bortezomib ( PS - 341, Velcade ) increases the efficacy of trastuzumab (Herceptin) in HER - 2 - positive breast cancer cells in a synergistic manner [ J ]. Mol Cancer Ther, 2006, 5 (12) : 3042 -3051.
  • 3Aghajanian C, Dizon DS, Sabbatini P, et al. Phase Ⅰ trial of bortezomib and carboplatin in recurrent ovarian or primary peritoneal cancer [ J ]. J Clin Oncol, 2005, 23 (25) : 5943 - 5949.
  • 4Dreicer R, Petrylak D, Agus D, et al. Phase Ⅶ study of bortezomib plus docetaxel in patients with advanced androgen- independent prostate cancer [ J ]. J Clin Oncol, 2004, 22(14S) : 1208 - 1215.
  • 5孙启鑫,孟凡义,扶云碧,李利.硼替佐米单用或联合三尖杉酯碱体外诱导HL-60细胞凋亡实验研究[J].中国实验血液学杂志,2007,15(2):233-236. 被引量:15
  • 6邓敏,鞠晓东,屠鹏飞,樊东升,张俊,沈扬.管花苷B对抗H_2O_2诱导的PC12细胞凋亡[J].中国病理生理杂志,2008,24(9):1816-1821. 被引量:12
  • 7束晓梅,李振宏,陈雪梅,杜淑珍.谷氨酸诱导海马神经元凋亡涉及线粒体释放细胞色素C[J].中国病理生理杂志,2008,24(11):2162-2166. 被引量:13
  • 8Cory S, Huang DC, Adams JM. The Bcl -2 family: roles in cell survival and oncogenesis[ J]. Oncogene, 2003, 22 ( 53 ) : 8590 - 8607.
  • 9Mitsiades N, Mitsiades CS, Poulaki V, et al. Molecular sequelae of proteasome inhibition in human multiple myeloma cells[J]. Proc Natl Acad Sci USA, 2002, 99(22) : 14374 - 14379.
  • 10Nikrad M, Johnson T, Puthalalath H, et al. The proteasome inhibitor bortezomib sensitizes cells to killing by death receptor ligand TRAIL via BH3 - only proteins Bik andBIM[J]. Mol Cancer Ther, 2005, 4(3): 443 - 449.

二级参考文献36

  • 1张闻多,丁文惠.细胞凋亡与凋亡诱导因子[J].中国病理生理杂志,2006,22(9):1858-1862. 被引量:17
  • 2任文霞,弓清梅,赵鹰,李建强,刘卓拉.胆红素对大鼠急性肺损伤形成过程中氧自由基以及caspase-3表达的影响[J].中国病理生理杂志,2007,23(2):293-296. 被引量:15
  • 3何煜舟,丁美萍.木犀草素对H_2O_2氧化损伤的血管内皮细胞的影响[J].中国病理生理杂志,2007,23(7):1285-1288. 被引量:16
  • 4Ankarcrona M, Dypbukt JM, Bonfoco E, et al. Glutamate -induced neuron death:a succession of necrosis or apoptosis depending on mitochondrial function [ J ]. Neuron, 1995, 15(4) : 961 -963.
  • 5Hirashima Y, Kurimoto M, Nogami K, et al. Correlation of glutamate- induced apoptosis with caspase activities in cultured rat cerebrac cortical neurons [ J ]. Brain Res, 1999,849(1-2) :109 - 118.
  • 6Zhang Y, Bhavnani BR. Glutamate -induced apoptosis in primary cortical neurons is inhibited by equine estrogens via down - regulation of caspase - 3 and prevention of mitochondrial cytochrome C release [ J]. BMC Neurosci, 2005, 6(1):13 -20.
  • 7Zhang Y, Lu X, Bhavnani BR. Equine estrogens differentially inhibit DNA fragmentation induced by glutamate in neuronal ceils by modulation of regulatory proteins involved in programmed cell death [ J ]. BMC Neurosci, 2003, 4 (1) :32 -47.
  • 8Riedl SJ, Salvesen GS. The apoptosome: signalling platform of cell death [ J ]. Nat Rev Mol Cell Biol, 2007, 8 (5) :405 -413.
  • 9Boccadoro M,Morgan G,Cavenagh J.Preclinical evaluation of the proteasome inhibitor bortezomib in cancer.Cancer Cell Int,2005;5:18-27
  • 10D.L.斯佩克特著(黄培堂等译).细胞实验指南.北京:科学出版社.2001:108-109

共引文献37

同被引文献14

  • 1Pennisi A, Li X, Ling W, et al. The proteasome inhibitor, bortezomib suppresses primary myeloma and stimulates bone formation in myeloma- lous and nonmyelomatous bones in vivo[ J]. Am J Hematol, 2009, 84 (1):6-14.
  • 2Roccaro A M, Vacca A, Ribatti D. Bortezomib in the treatment of cancer[ J]. Recent Pat Anticancer Drug Discov, 2006, 1 (3) : 397 - 403.
  • 3Reddy K G. Activity of bortezomib in advanced non-small-cell lung cancer[J]. Clin Lung Cancer, 2004, 6(3) : 141 -142.
  • 4Fernandez Y, Miller T P, Denoyelle C, et al. Chemical blockage of the proteasome inhibitory function of bortezomib : impact on tumor cell death[J].J Biol Chem, 2006, 281(2) : 1107 -1118.
  • 5Canfield S E, Zhu K, Williams S A, et al. Bortezomib inhibits do- cetaxel-induced apoptosis via a p21-dependent mechanism in human prostate cancer ceils [ J ]. Mol Cancer Ther, 2006, 5 (8) : 2043 - 2050.
  • 6Lashinger L M, Zhu K, Williams S A, et al. Bortezomib abolishes tumor necrosis factor-related apoptosis-inducing ligand resistance via a p21-dependent mechanism in human bladder and prostate cancer cells [J]. CancerRes, 2005, 65(11):4902-4908.
  • 7Huang C Y, Wei C C, Chen K C, et al. Bortezomib enhances radia- tion-induced apoptosis in solid tumors by inhibiting CIP2A[J]. Cancer Lett, 2012, 317(1 ): 9- 15.
  • 8Sun L, Zhang L, Qian J, et al. Combination of atiprimod and the pro- teasome inhibitor bortezomib induces apoptosis of mantle cell lymphoma in vitro and in vivo[J]. Leuk Res, 2012, 36(3) : 363 -368.
  • 9Albero M P, Vaquer J M, Andreu E J, et al. Bortezomib decreases Rb phosphorylation and induces caspase-dependent apoptosis in ima- tinib-sensitive and-resistant Bcr-Abll-expressing cells[J]. Oncogene, 2010, 29(22): 3276-3286.
  • 10Brooks A D, Jacobsen K M, Li W, et al. Bortezomib sensitizes hu- man renal cell carcinomas to TRAIL apoptosis through increased acti- vation of caspase-8 in the death-inducing signaling complex[J]. Mol Cancer Res, 2010, 8(5) : 729 -738.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部